“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism

Background: “Pill-in-the-pocket” (PIP) treatment with type IC drugs for cardioversion of recent-onset atrial fibrillation (AF) has been recommended in guidelines. Major adverse effects have been often reported, and the underlying mechanisms are proposed to be associated with the genetic backgrounds....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linling, Ruan, Yanfei, Liu, Nian, Zhao, Qianqian, Zhang, Mengxia, Li, Xin, Zuo, Song, Le, Jiang, Wu, Kui, Bai, Rong, Ma, Changsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450223/
https://www.ncbi.nlm.nih.gov/pubmed/30984031
http://dx.doi.org/10.3389/fphys.2019.00353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450223/
https://www.ncbi.nlm.nih.gov/pubmed/30984031
http://dx.doi.org/10.3389/fphys.2019.00353

Ejemplares similares